Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma
Coherus Oncology, Inc.
Coherus Oncology, Inc.
Centre Oscar Lambret
Tanta University
Institute of Oncology Ljubljana
University of California, San Diego
Next Biomedical Co., Ltd.
Lund University Hospital
Stanford University
Guangxi Medical University
University Hospital, Tours
Istanbul Medipol University Hospital
Coherus Oncology, Inc.
University of Southern California
UNC Lineberger Comprehensive Cancer Center
MacroGenics
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
The University of Texas Health Science Center at San Antonio
Washington University School of Medicine
The First Affiliated Hospital of Xiamen University
University Hospital Plymouth NHS Trust
Sir Run Run Shaw Hospital, Qingchun Campus, Zhejiang University School of Medicine,
Thomas Jefferson University
Novita Pharmaceuticals, Inc.
University of Texas Southwestern Medical Center
Federation Francophone de Cancerologie Digestive
Bayer
Thomas Jefferson University
San Camillo Hospital, Rome
Peking University First Hospital
Tvardi Therapeutics, Incorporated
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Intensity Therapeutics, Inc.
Alliance for Clinical Trials in Oncology
Sirtex Medical
Fox Chase Cancer Center
Memorial Sloan Kettering Cancer Center
ABK Biomedical
Bristol-Myers Squibb
GenVivo, Inc.
Baylor College of Medicine
Taiho Oncology, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Imunon
VA Office of Research and Development
Ethicon, Inc.
Xencor, Inc.
Sichuan Cancer Hospital and Research Institute
University of Edinburgh